Historique du chiffre d'affaires, des bénéfices et des flux de trésorerie d'après les états financiers officiels.
IDEX Corporation, avec ses filiales, fournit des solutions appliquées aux États-Unis, en Amérique du Nord, en Europe, en Asie et à l'international. Elle opère à travers trois segments : Health & Science Technologies (HST), Fluid & Metering Technologies (FMT) et Fire & Safety/Diversified Products (FSDP).
Traduit automatiquement
Voir les graphiques interactifs et les états complets → Modèle de valorisation (DCF) →
| Compte de résultat | TTM → 2026-09-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiffre d'affaires total | $3.7B | $3.5B | $3.3B | $3.3B | $3.2B | $2.8B | $2.4B | $2.5B | $2.5B | $2.3B | $2.1B | $2.0B | $2.1B | $2.0B | $2.0B | $1.8B | $1.5B | $1.3B | $1.5B | $1.4B | $1.2B |
| Bénéfice brut | $1.6B | $1.5B | $1.5B | $1.4B | $1.6B | $1.4B | $1.2B | $1.3B | $1.2B | $1.1B | $985M | $941M | $987M | $908M | $840M | $791M | $650M | $551M | $627M | $597M | $502M |
| Marge brute % | 44.9% | 44.5% | 46.4% | 44.2% | 50.1% | 49.2% | 49.2% | 51.1% | 46.9% | 46.7% | 46.6% | 46.6% | 46.0% | 44.9% | 43.0% | 43.0% | 43.0% | 41.4% | 42.1% | 43.9% | 43.5% |
| Résultat opérationnel (EBIT) | $766M | $720M | $697M | $732M | $790M | $654M | $537M | $602M | $584M | $503M | $451M | $431M | $448M | $399M | $359M | $339M | $260M | $196M | $254M | $255M | $217M |
| Marge opérationnelle % | 20.9% | 20.8% | 21.3% | 22.4% | 24.8% | 23.6% | 22.8% | 24.1% | 23.5% | 22.0% | 21.3% | 21.3% | 20.8% | 19.7% | 18.4% | 18.5% | 17.2% | 14.7% | 17.1% | 18.8% | 18.8% |
| Résultat net | $535M | $483M | $505M | $596M | $587M | $449M | $378M | $426M | $411M | $337M | $271M | $283M | $279M | $255M | $38M | $194M | $157M | $113M | $131M | $155M | $147M |
| Marge nette % | 14.6% | 14.0% | 15.4% | 18.2% | 18.4% | 16.2% | 16.1% | 17.1% | 16.5% | 14.7% | 12.8% | 14.0% | 13.0% | 12.6% | 1.9% | 10.5% | 10.4% | 8.5% | 8.8% | 11.4% | 12.7% |
| EBITDA | — | $904M | $859M | $732M | $910M | $720M | $605M | $648M | $657M | $591M | $508M | $505M | $504M | $467M | $199M | $369M | $306M | $234M | $260M | $290M | $247M |
| Bénéfice par action (EPS) | $7.21 | $6.42 | $6.65 | $7.85 | $7.72 | $5.88 | $4.95 | $5.57 | $5.29 | $4.36 | $3.53 | $3.63 | $3.46 | $3.09 | $0.45 | $2.32 | $1.92 | $1.40 | $1.60 | $1.89 | $1.81 |
| Actions en circulation (M) | — | 75M | 76M | 76M | 76M | 76M | 76M | 76M | 78M | 77M | 77M | 78M | 81M | 82M | 84M | 84M | 82M | 81M | 82M | 82M | 81M |
Source : rapports publics de la société (SEC). Vérifiez sur SEC EDGAR avant de vous fier à tout chiffre.
Bilans, flux de trésorerie, données trimestrielles et ratios complets dans le visualiseur interactif de IEX. /companies/us/IEX
Les informations de ce site sont fournies à des fins éducatives et informatives uniquement ; elles ne constituent pas un conseil en investissement. Aucun objectif de cours ni recommandation n'est publié.
About TickerBase · Data methodology & sources · Privacy · Terms